Insider Transactions in Q3 2021 at Pmv Pharmaceuticals, Inc. (PMVP)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 22
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
200
-0.01%
|
$7,000
$35.61 P/Share
|
Jul 21
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
18,672
-0.92%
|
$653,520
$35.82 P/Share
|
Jul 21
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
26,767
-68.22%
|
$936,845
$35.76 P/Share
|
Jul 21
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,767
+40.55%
|
$0
$0.53 P/Share
|
Jul 20
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
1,029
-7.62%
|
$36,015
$35.53 P/Share
|
Jul 20
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,029
+7.08%
|
$0
$0.53 P/Share
|
Jul 20
2021
|
Arnold J Levine |
SELL
Open market or private sale
|
Direct |
3,500
-0.83%
|
$122,500
$35.12 P/Share
|
Jul 13
2021
|
Interwest Partners X LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
125,863
+47.33%
|
-
|
Jul 13
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
97,632
-100.0%
|
-
|
Jul 13
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
500,000
-10.06%
|
-
|
Jul 08
2021
|
Winston Kung COO, CFO |
SELL
Open market or private sale
|
Direct |
4,500
-73.77%
|
$148,500
$33.75 P/Share
|
Jul 08
2021
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.45%
|
$13,500
$3.22 P/Share
|
Jul 07
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-74.39%
|
$128,000
$32.3 P/Share
|
Jul 07
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|